Thank you, Mr. Chair.
Thank you to our panel, again, this morning.
I have a whole bunch of different questions. This is obviously the first testimony that we've heard on this topic, so it's a real eye-opener in some ways.
One of the things that I was quite intrigued with early on...and just as a point of background, when we decided to engage in this topic, we initially considered that we wouldn't be that interested in the criminal side of it so much. I see by your presentation here today that in fact it very much encompasses that, because one part of the toolbox is going to be the criminal side, if you will.
Actually, the chair jumped on a question that I wanted to spend a bit of time with as well, and maybe I'll build on that.
In terms of that toolbox, your office will be part of that. We've already spent some time on PIPEDA. I wonder if you could continue on along the same lines. I noticed that in your remarks you talked about some additional measures that could be taken in the Privacy Act. What other things do you see your office providing in terms of leadership and moving this forward?